Abstract Recent evidence suggests that an insertion/deletion (I/D) polymorphism of the gene encoding angiotensinconverting enzyme (ACE) is associated with myocardial infarction and related cardiovascular diseases. We investigated a possible association of the ACE polymorphism with essential hypertension in a total of 263 cases/controls from among the elderly (age, over 70 years) and middle-aged (age between 30 and 60 years) Japanese population. The frequency of the I/I homozygote was significantly higher in hypertensive subjects than in controls in the elderly age group (33/57 vs 16/46; P ϭ 0.02), but no association was observed in the middle-aged group (25/75 vs 26/85; P ϭ 0.71). Similarly, having at least one insertion allele was associated with essential hypertension in the elderly age group (83/114 vs 46/92 in controls; P ϭ 0.001), but not in the middle-aged group (78/150 vs 94/170; P ϭ 0.524). These data suggest that genetic variation at the ACE locus may be associated with some determinants for blood pressure in elderly persons, and imply the involvement of the ACE insertion/deletion polymorphism in the etiology of agerelated essential hypertension in the Japanese population.
Introduction
The renin-angiotensin system plays an important role in the regulation of blood pressure and the maintenance of vascular tone (Tamura et al. 1995) . Angiotensin II, an endproduct of this system, is a vasoactive octapeptide whose effects include vasoconstriction, production of aldosterone, and enhancement of noradrenaline release from sympathetic nerve endings (Timmermans et al. 1993) . Under pathological conditions, this system could influence the development and progression of cardiovascular diseases. To clarify the pathophysiological role of vasoactive substances, we and others have studied polymorphisms of several genes for potential associations with such diseases (Umemura et al. 1994; Ishigami et al. 1995a,b) .
A genetic polymorphism of the human angiotensin Iconverting enzyme (ACE), which converts angiotensin I to angiotensin II, appears to be an independent risk factor for myocardial infarction (Cambien et al. 1992; Evans et al. 1994) . This polymorphism occurs within intron 16 of the ACE gene, in the form of the insertion or deletion (I/D) of a 287-bp Alu sequence (Rigat et al. 1992) . Several cardiovascular diseases have been studied with respect to this polymorphism, which does appear to be associated with left ventricular hypertrophy (Iwai et al. 1994; Schunkert et al. 1994) , with coronary atherosclerosis in smokers , with hypertrophic cardiomyopathy (Marian et al. 1993) , with re-stenosis after percutaneous transluminal coronary angioplasty (PTCA; Ohishi et al. 1993) , and with vasospastic angina pectoris (Oike et al. 1995) . In addition, increased severity of IgA nephropathy (Harden et al. 1995; Yoshida et al. 1995) , chronic renal failure (Nomura et al. 1994 ) and carotid artery plaque (Watanabe et al. 1997) have been described in patients with a specific genotype, although such results are not consistently observed in other studies (Lindpaintner et al. 1995; Montgomery et al. 1995; Tarnow et al. 1995) .
Efforts to establish an association between essential hypertension and the ACE gene I/D polymorphism have been undertaken in different human populations, sometimes with negative results (Harrap et al. 1993; Higashimori et al. 1993; Schmidt et al. 1993; Ishigami et al. 1995a ), although others have described a positive correlation (Zee et al. 1992; Morris et al. 1994) . The results of some of these studies suggest that the effect of the ACE polymorphism in the etiology of hypertension may vary according to whether patients are classified by sex, race, or age. In the present study, we investigated whether the I/D polymorphism of ACE correlated with hypertension in age-classified groups of Japanese cases and controls.
Subjects and methods
Subjects and isolation of DNA Adult Japanese subjects were randomly selected from among patients with essential hypertension who had been followed at the Yokohama City University Hospital, and from among persons who had come for routine health checkups (i.e., our control population). Informed consent was obtained, in the formal style approved by the Ethics Committee of the Yokohama City University Hospital, before any person was enrolled in this study. Blood samples were drawn for the extraction of genomic DNA and for the measurement of serum cholesterol, triglyceride, and highdensity lipoprotein (HDL) cholesterol.
ACE genotypes were analyzed in a total of 263 subjects (132 hypertensive patients and 131 normotensive subjects). Patients were diagnosed as having essential hypertension according to the criteria of the World Health Organization, i.e., primary hypertension with systolic blood pressure (SBP) of more than 140 mmHg and/or diastolic blood pressure (DBP) of more than 90 mmHg. Genomic DNA was extracted from these patients' peripheral blood leukocytes by standard methods, using proteinase K digestion of the nuclei (Sambrook et al. 1989) , and was isolated by ethanol precipitation from phenolic extracts.
Genotyping for the ACE I/D polymorphism
We amplified the portion of intron 16 of the ACE gene that contains the polymorphic insertion/deletion by means of the polymerase chain reaction (PCR). The senseoligonucleotide primer was 5Ј-CTG GAC ACC ACT CCC ATC CTT TCT-3Ј and the antisense primer was 5Ј-GAT GTG GCC ATC ACA TTC GTC AGA T-3Ј (Rigat et al. 1992) . Each reaction was performed in a final volume of 50 µl, containing 10 pmol of each primer, 5 mM MgCl2, 50 mM KCl, 10mM Tris-HCl (pH 8.4), 0.1 mg/ml gelatin, 0.5 µM of each dNTP, and 1 unit of Taq polymerase (TaKaRa, Tokyo, Japan). Because the standard method of ACE genotyping (Rigat et al. 1992 ) may have led to missassignment of genotype, we added 5% dimethyl sulfoxide to the reaction mixture. Amplification was carried out in a DNA Thermal Cycler (PE Biosystems, Tokyo, Japan) for 30 cycles. Each cycle included denaturation at 94°C for 1min, annealing at 58°C for 1 min, and extension at 72°C for 1min. The PCR products were electrophoresed in 1.6% agarose gels, and then visualized by ethidium bromide staining. Homozygotes for this polymorphism showed either a single 490-bp band, named I/I, or a 190-bp band (D/ D); DNA from heterozygotes (I/D) produced both bands.
Statistical analyses
The values for the data on clinical and biological characteristics of the subject groups were expressed as means Ϯ SE, and analyzed by Student's t-test. Genotypic data were sorted into categories according to the ages of patients and controls, and allelic frequencies were calculated for each group. Differences between groups were tested by 2 analysis after the construction of an adequate contingency table.
Results
Background data for the hypertensive and normotensive subjects in the elderly (age, over 70 years) and middle-aged (age between 30 and 60 years) groups in our panel of 263 subjects are summarized in Table 1 . We found no significant differences between hypertensive and normotensive subjects in either age group with respect to mean age, body mass index, total cholesterol, or triglyceride concentrations. Tables 2 and 3 show genotype frequencies (I/I, I/D, and D/D) and allele frequencies (I or D) for the ACE polymorphism in hypertensive and normotensive elderly and middle-aged subjects, respectively. I/I homozygotes were significantly more frequent among elderly hypertensive subjects than in controls (33/57 vs 16/46; P ϭ 0.02), but no association was observed in the middle-aged group (cases, 25/75 vs controls, 26/85; P ϭ 0.71).
Statistical analysis of allele frequencies indicated that the presence of at least one I allele was associated with essential hypertension in the elderly age group (83/114 vs controls, 46/92; P ϭ 0.001; Table 2 ), but not in the middle-aged group (78/150 vs 94/170; P ϭ 0.524; Table 3 ). The distribution of alleles in each age group did not deviate significantly from Hardy-Weinberg equilibrium among cases and controls.
Discussion
Animal cross-breeding studies involving stroke-prone, spontaneously hypertensive rats and Wistar-Kyoto rats have linked the ACE locus to high blood pressure (Hilbert et al. 1991; Jacob et al. 1991) . Association studies between essential hypertension and the ACE gene I/D polymorphism have also been performed in various human populations. Some research groups have failed to observe any correlation (Harrap et al. 1993; Higashimori et al. 1993; Schmidt et al. 1993; Ishigami et al. 1995a ), but others have reported significant correlation (Zee et al. 1992; Morris et al. 1994) . Some previous studies (Zee et al. 1992; Morris et al. 1994 ) described a positive association of hypertension with the ACE gene D allele, rather than the I allele that was associated with hypertension in the present study. Such a discrepancy could result from various factors, as follows. The allele distribution of polymorphisms may be different in different countries or even in different areas of the same country. Indeed, the allele distribution of the normotensives listed in Table 2 , who were collected in the Yokohama area of Japan, is different from that reported in previous studies, as mentioned above. In addition, because our study sample size was relatively small, the remote possibility of a false-positive result can not be ruled out.
Observations of genetic linkage, as well as association between the ACE locus and blood pressure, tend to be stronger when the study population is restricted to men, as in the Framingham Heart Study, in which diastolic pressure was associated with D genotype in men (O'Donnell et al. 1998 ), or to young Caucasian men (Fornage et al. 1998 ). In addition, Turner et al. (1999) reported that an ACE I/D polymorphism was associated with blood pressure in a sexand age-dependent manner. Furthermore, ethnic differences in the frequencies of the I and D alleles of the ACE gene (Barley et al. 1994; Lee 1994; Ishigami et al. 1995a,b) and in the serum activity of this enzyme have complicated the comparison of data among different population samples (Bloem et al. 1996) . In the present study, we investigated the ACE I/D polymorphism for correlation with essential hypertension in age-classified groups of Japanese cases and controls. Morris et al. (1994) had observed that the D/D genotype at the ACE locus was less common in elderly hypertensive Caucasian patients than in age-matched controls. We have demonstrated here an association between increased frequency of the ACE insertion allele in older Japanese patients with essential hypertension, but not in the younger Japanese patients. Our data accord, in general, with the observations of Morris et al. (1994) , although the frequencies of the genotypes and alleles were quite different in the Japanese and Caucasian test populations. The results reported here support an idea suggested by O'Donnell et al. (1998) , Fornage et al. (1998), and Turner et al. (1999) , that the role of ACE gene variation in the etiology of essential hypertension may differ according to the type of disease and/or the sex, race, or age of the patients.
Previous studies have suggested that the D allele of the ACE gene was associated with several cardiovascular diseases, such as left ventricular hypertrophy (Iwai et al. 1994; Schunkert et al. 1994) , coronary atherosclerosis in smokers , hypertrophic cardiomyopathy (Marian et al. 1993) , re-stenosis after percutaneous transluminal coronary angioplasty (PTCA; Ohishi et al. 1993) , and vasospastic angina pectoris (Oike et al. 1995) . Increased plasma activity of the ACE enzyme correlates with thickening of the wall of the carotid artery (Bonithon-Knopp et al. 1994 ). In addition, Danser et al. (1995) reported higher levels of atrial ACE mRNA in humans with the D/D genotype than in subjects with other genotypes. Another report suggested that renin-angiotensin activity in rat plasma declined with age (Costerousse et al. 1994) . Also, in rat models, mRNA levels of both angiotensinogen and ACE increased in the left ventricle during senescence, while the activity of the renin-angiotensin system decreased in the plasma (Heymes et al. 1994) . Local activation of the renin-angiotensin system may induce remodeling of the vasculature, which could lead to a variety of cardiovascular and other consequences.
The present study indicates that age should be considered in the evaluation of data concerning ACE genotypes, especially for patients with essential hypertension. In this connection, it is intriguing to note an association between the DD genotype and longevity described by Schachter et al. (1994) . Those investigators suggested that the association with longevity may indicate the presence of mechanisms such as improvement in the repair of damaged tissues, or increased resistance to neoplasia and infection (Costerousse et al. 1993; Luft 1999) . One might also find beneficial effects on neurons in aged subjects in relation to genetic variations at the ACE locus. In light of these ideas, it would be intriguing to determine ACE genotypes in Japanese centenarians.
In conclusion, we suggest that certain genetic variations at the ACE locus may be associated with some determinants for blood pressure in the elderly, and that the insertion/deletion polymorphism may be involved in the etiology of essential hypertension in this age group in Japan.
